TabsDetailsBasic DetailsDate: Thursday, January 19, 2012Type: PublicationHealth Outcome(s): interstitial lung diseasepulmonary fibrosisDescription: This article describes a systematic review of the validity of algorithms for identifying pulmonary fibrosis and interstitial lung disease using administrative and claims data. Read More Materials: Pharmacoepidemiology and Drug Safety, Volume 21, Issue Supplement S1, January 2012, Pages 256-260, DOI: 10.1002/pds.2338Additional InformationRelated Assessment(s): HOI Literature Review - Pulmonary FibrosisPDS Supplement: The U.S. Food and Drug Administration's Mini-Sentinel ProgramContributorsAuthor(s): Natalie Jones BS; Gary Schneider ScD, MSPH; Sumesh Kachroo PhD; Philip Rotella MS; Ruzan Avetisyan MD, MPH; Matthew W. Reynolds PhD; United BioSource Corporation, Epidemiology and Database Analytics, Lexington, MACorresponding Author: G. Schneider, Center for Epidemiology and Database Analytics, United BioSource Corporation, 430 Bedford St., Suite 300, Lexington, MA, 02420 USA. E-mail: gary.schneider@unitedbiosource.com
